Is pioglitazone hydrochloride associated with an increased risk of bone fractures in women?

Yes, pioglitazone hydrochloride was associated with increased bone fractures in women in pooled randomised controlled trials lasting up to 3.5 years, with fractures in 2.6% receiving pioglitazone versus 1.7% receiving a comparator.